Provisional Curricular Framework & Timetable

Provisional Scientific Program & Curricular Syllabus

This syllabus outlines the programmatic timetable and curricular distribution for CGSF 2027. Operating under rolling peer-review governance, session time blocks reflect locked scientific contact allocations designed for university grant clearance, institutional travel/education approval, and attendee auditing. The assembly delivers 12.0 Certified Educational Contact Hours (9.5 Plenary, 2.5 Defense & Q&A) across April 21–22, 2027.

Total Certified Hours 12.0 Certified Hours Serialized Tracking ID
Curriculum Division 9.5 Plenary | 2.5 Defense Synchronous Delivery
Academic Governance Rolling Review Model Proffered & Invited Podiums
Assembly Window April 21–22, 2027 08:45–15:30 EDT Daily
Institutional Verification & Session Audit Notice: Certified Educational Contact Hours are granted based on verified synchronous virtual attendance. Post-forum, the Secretariat issues an official Certificate of Participation displaying an auditable verification ID for departmental seminar clearances, fellowship milestones, and university Faculty Activity Reporting (FAR). Cardholder transactions reflect on institutional accounts as CATALYST RESEARCH / CATALYSTRSC.
08:45 – 09:00 EDT 12:45 – 13:00 UTC Administrative Protocol (0.0 Contact Hours)

Colloquium Check-In & Secretariat Orientation

Virtual platform check-in, delegate credential verification, attendance logger initialization, and instructions for synchronous Q&A defense rooms.

09:00 – 10:30 EDT 13:00 – 14:30 UTC
Plenary Session I 1.5 Certified Contact Hours

Track 01 Plenary: High-Throughput Cytotoxicity & Natural Product Mechanistic Assays

Systematic evaluation of in vitro screening architectures for secondary plant metabolites and crude botanical fractions. Topics cover selective cytotoxicity indices (SI), mitochondrial membrane potential depolarization, autophagic flux versus apoptotic pathways, and standardized IC50 benchmarking across solid tumor lines.

Auditing Scope: Quantitative assessment of MTT/CCK-8 viability assays, Annexin V/PI flow cytometry gating strategies, fluorescent mitochondrial membrane potential (JC-1) quantification, and standard deviation benchmarking for half-maximal inhibitory concentrations (IC50).
Session Leadership: Scientific Track 01 Working Group & Assigned Session Co-Chairs
Format: Synchronous Plenary Lectures & Moderated Methodological Defense
Curriculum: Track 01 Discovery & Assays (1.5 Certified Hours)
10:30 – 11:45 EDT 14:30 – 15:45 UTC
Oral Defense Panel I 1.25 Certified Contact Hours

Oral Abstract Defense & Investigator Q&A: Preclinical Assays & Early-Phase Biomarkers

Synchronous defense of peer-reviewed proffered abstracts across Tracks 01 and 02. Presenting authors deliver structured data summaries followed by live methodological defense before session chairs and registered delegates. Observers audit comparative protocol designs, statistical validation, and negative control standards.

Session Leadership: Tracks 01 & 02 Review Committee Co-Chairs
Presentation Roster: Proffered Papers & Oral Abstract Defenses (Rolling Allocation Under Editorial Review)
Format: Structured Investigator Addresses & Live Cross-Floor Defense (1.25 Certified Hours)
11:45 – 12:15 EDT 15:45 – 16:15 UTC Recess (0.0 Contact Hours)

Midday Intermission & Digital Exhibition

Delegate recess. Virtual rooms open for technical demonstrations, diagnostic assay briefs, and syllabus review.

12:15 – 13:45 EDT 16:15 – 17:45 UTC
Plenary Session II 1.5 Certified Contact Hours

Track 02 Plenary: Clinical NGS Panels, Variant Calling & Epigenetic Alterations

Translating next-generation sequencing output into actionable molecular diagnostics. Methodological appraisal of targeted multigene panels versus whole-exome sequencing (WES), depth-of-coverage considerations, variant allele fraction (VAF) interpretation under AMP/ASCO/CAP guidelines, and bisulfite sequencing parameters.

Auditing Scope: Review of high-depth targeted NGS output (mean depth >500x), distinguishing subclonal vs clonal variant allele fractions (VAF), quality scoring criteria under AMP/ASCO/CAP somatic classification standards, and bisulfite sequencing readout metrics.
Session Leadership: Scientific Track 02 Working Group & Genomic Diagnostics Chairs
Format: Synchronous Plenary Lectures & Variant Curation Synthesis
Curriculum: Track 02 High-Throughput Diagnostics (1.5 Certified Hours)
13:45 – 15:30 EDT 17:45 – 19:30 UTC
Plenary Session III 1.75 Certified Contact Hours

Track 02 Plenary: Liquid Biopsy Assays & Minimal Residual Disease (MRD) Dynamics

Investigation of circulating tumor DNA (ctDNA) kinetics, cell-free RNA signatures, and analytical limit-of-detection (LoD) standards. Focus on longitudinal monitoring of treatment response, subclonal divergence, and clinical validation criteria for non-invasive biomarker platforms in oncology.

Auditing Scope: Evaluation of digital PCR (dPCR) and hybrid-capture NGS detection thresholds (limit of detection ≤0.01% VAF), longitudinal ctDNA kinetics tracking during systemic therapy, and false-positive filtering for clonal hematopoiesis of indeterminate potential (CHIP).
Session Leadership: Molecular Biomarkers Working Group & Appointed Session Co-Chairs
Format: Synchronous Plenary Addresses & Longitudinal Assay Discussion
Day 1 Total: 4.75 Plenary + 1.25 Defense = 6.0 Certified Contact Hours
08:50 – 09:00 EDT 12:50 – 13:00 UTC Administrative Protocol (0.0 Contact Hours)

Day 2 Reconvening & Attendance Re-Verification

Morning sign-in verification for certified contact hour logs, curriculum notices, and technical check for afternoon defense participants.

09:00 – 10:30 EDT 13:00 – 14:30 UTC
Plenary Session IV 1.5 Certified Contact Hours

Track 03 Plenary: CAR-T, CAR-NK & TCR-T Construct Architectures

Engineering next-generation biological effector cells for targeted immunotherapy. Comparative examination of scFv binding affinity, costimulatory domain selection (4-1BB vs CD28), non-viral transposon gene integration, and clinical protocols for monitoring cytokine release syndrome (CRS) and neurotoxicity.

Auditing Scope: Structural domain mapping of 2nd- vs 4th-generation CAR constructs, lentiviral vs transposon-mediated integration copy number analysis, in vitro cell-mediated cytotoxicity (chromium-51/luminescence release), and real-time cytokine secretion quantification (IL-6, IFN-gamma, TNF-alpha).
Session Leadership: Scientific Track 03 Working Group & Appointed Session Co-Chairs
Format: Synchronous Plenary Lectures & Construct Optimization Review
Curriculum: Track 03 Cellular Therapeutics (1.5 Certified Hours)
10:30 – 11:45 EDT 14:30 – 15:45 UTC
Oral Defense Panel II 1.25 Certified Contact Hours

Oral Abstract Defense & Investigator Q&A: Cellular Engineering & Resistance Biology

Synchronous defense of peer-reviewed abstracts covering synthetic cellular constructs, immunosuppression reversal, and resistance pathway bypass. Presenting investigators address inquiries from senior review chairs and registered delegates regarding construct durability and combination study designs.

Session Leadership: Tracks 03 & 04 Scientific Review Co-Chairs
Presentation Roster: Proffered Papers & Investigator Oral Defenses (Rolling Allocation Under Editorial Review)
Format: Structured Investigator Data Addresses & Live Cross-Floor Defense (1.25 Certified Hours)
11:45 – 12:15 EDT 15:45 – 16:15 UTC Recess (0.0 Contact Hours)

Midday Intermission & Educational Networking

Colloquium recess. Virtual breakout corridors open for participant discussion and technical prospectus inspection.

12:15 – 13:45 EDT 16:15 – 17:45 UTC
Plenary Session V 1.5 Certified Contact Hours

Track 03 Plenary: Overcoming Solid Tumor Microenvironment Immunosuppression

Investigating physical and biochemical stromal barriers limiting cellular infiltration. Mechanisms of T-cell exhaustion, checkpoint co-expression (LAG-3, TIM-3, TIGIT), Boolean logic gates (AND/OR/NOT constructs), and synthetic cytokine remodeling to enhance effector cell durability in solid tumors.

Auditing Scope: Histopathological appraisal of cancer-associated fibroblast (CAF) dense stroma barriers, multi-parameter flow cytometry panels for exhaustion phenotypes (PD-1, TIM-3, LAG-3), and synthetic biology logic gate circuitry (AND/NOT split-CAR activation assays).
Session Leadership: Track 03 Immunobiology Working Group & Appointed Session Co-Chairs
Format: Synchronous Plenary Lectures & Microenvironment Overcoming Strategies
Curriculum: Track 03 Microenvironment Navigation (1.5 Certified Hours)
13:45 – 15:30 EDT 17:45 – 19:30 UTC
Plenary Session VI 1.75 Certified Contact Hours

Track 04 Plenary: Secondary Kinase Mutations, ADC Payloads & Rational Combinations

Characterizing acquired bypass circuitry and gatekeeper resistance mutations following frontline targeted small molecules. Examination of antibody-drug conjugate (ADC) linker kinetics, bystander effect optimization, synthetic lethality models, and multi-axis combination paradigms. Concludes with the Secretariat curriculum review and contact hour validation.

Auditing Scope: Mutational profiling of secondary gatekeeper substitutions (e.g., EGFR T790M/C797S, KRAS G12C bypasses), ADC internalization kinetics assays, calculation of drug-to-antibody ratios (DAR) via mass spectrometry, and bliss-independence synergy matrix models.
Session Leadership: Track 04 Resistance Biology Working Group & Colloquium Secretariat
Format: Synchronous Plenary Lectures & Curricular Synthesis
Day 2 Total: 4.75 Plenary + 1.25 Defense = 6.0 Certified Contact Hours
Delegate Clearance Desk

Audit the Live Curriculum as a Non-Presenting Scientific Delegate

Secure early institutional clearance to audit 12.0 Certified Educational Contact Hours across all plenary lectures and moderated defense sessions without abstract obligations. Registration includes live interactive Q&A privileges, proceedings syllabus access, and a serialized Certificate of Participation for university FAR documentation.

Scroll to Top